Aisha Noreen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aisha Noreen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Adeela Khurshid
Department of Pharmaceutics, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Gadap Road, Super Highway, Karachi 75340, Pakistan
1 shared publicationAnum Akram
Indus Hospital, Karachi, Pakistan
1 shared publicationIqbal Ahmad
Department of Pharmaceutical Chemistry, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Gadap Road, Super Highway, Karachi 75340, Pakistan
1 shared publicationMaryam Inayat
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
1 shared publicationMuhammad Ahsan Ejaz
Department of Pharmaceutical Chemistry, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Gadap Road, Super Highway, Karachi 75340, Pakistan
1 shared publicationMuhammad Ali Sheraz
Department of Pharmaceutics, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Gadap Road, Super Highway, Karachi 75340, Pakistan
1 shared publication
Latest Publications
- 5 January 2024
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 309, 123813
Riboflavin (vitamin B2) sensitized photooxidation of ascorbic acid (vitamin C): A kinetic study
- 5 January 2024
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 309, 123813
Riboflavin (vitamin B2) sensitized photooxidation of ascorbic acid (vitamin C): A kinetic study
- Open Access
- 13 February 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (1) , 68-75
In-vivo Hypoglycemic Activity of Grewia asiatica Fruit Extract in Streptozotocin Mediated Diabetic Rats
Diabetes mellitus has high global prevalence and occurrence and is considered to bean endocrinological and/or metabolic disorder. Conventional drug treatment is costly and has toxic side effects, although it is successful in treating diabetes mellitus. If effective and less toxic, herbal medicine will thus include alternative therapy. This research has been designed to investigate the role of Grewia asiatica extract in the control of diabetes in male albino rats with Streptozotocin mediated type 2 diabetes. Grewia asiatica fruit extract at a dose of 200mg/kg was given to Streptozotocin mediated type II DM Rats. A known anti-diabetic drug, Glibenclamide has been used as a standard drug. The method of the research was to monitor the effect of Grewia asiatica on the blood glucose level of Rats. In this study, Rats were split into four categories i.e. Control, Streptozotocin treated, Streptozotocin + Glibenclamide treated and Streptozotocin +Grewia asiatica extract-treated group. Grewia asiatica fruit extract significantly improve the blood glucose levels as compared to the standard drug Glibenclamide in Streptozotocin mediated diabetic group. Conclusion: It was concluded that Grewia asiatica may be used in the treatment of diabetes or decreasing the elevated level of blood sugar.
- 13 February 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (1) , 68-75
Open AccessIn-vivo Hypoglycemic Activity of Grewia asiatica Fruit Extract in Streptozotocin Mediated Diabetic Rats
Diabetes mellitus has high global prevalence and occurrence and is considered to bean endocrinological and/or metabolic disorder. Conventional drug treatment is costly and has toxic side effects, although it is successful in treating diabetes mellitus. If effective and less toxic, herbal medicine will thus include alternative therapy. This research has been designed to investigate the role of Grewia asiatica extract in the control of diabetes in male albino rats with Streptozotocin mediated type 2 diabetes. Grewia asiatica fruit extract at a dose of 200mg/kg was given to Streptozotocin mediated type II DM Rats. A known anti-diabetic drug, Glibenclamide has been used as a standard drug. The method of the research was to monitor the effect of Grewia asiatica on the blood glucose level of Rats. In this study, Rats were split into four categories i.e. Control, Streptozotocin treated, Streptozotocin + Glibenclamide treated and Streptozotocin +Grewia asiatica extract-treated group. Grewia asiatica fruit extract significantly improve the blood glucose levels as compared to the standard drug Glibenclamide in Streptozotocin mediated diabetic group. Conclusion: It was concluded that Grewia asiatica may be used in the treatment of diabetes or decreasing the elevated level of blood sugar.